Navigation Links
Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023
Date:9/2/2013

e World Market for Biosimilar MAbs: Revenues ($m) and Market Shares (%) by Compound, 2018 and 2023

Table 3.4 Major Originator Biologic Products: EU and US Patent Expiry Dates

Table 3.5 Biosimilar MAbs: Revenue Forecasts ($m) by Molecule, 2012-2023

Table 3.6 Biosimilar Infliximab: Compounds in the Pipeline, 2013

Table 3.7 Biosimilar Infliximab: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 3.8 Biosimilar Rituximab: Compounds in the Pipeline, 2013

Table 3.9 Biosimilar Rituximab: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 3.10 Biosimilar Abciximab: Compounds in the Pipeline, 2013

Table 3.11 Biosimilar Abciximab: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 3.12 Biosimilar Trastuzumab: Compounds in the Pipeline, 2013

Table 3.13 Biosimilar Trastuzumab: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 3.14 Biosimilar Adalimumab: Compounds in Development, 2013

Table 3.15 Biosimilar Adalimumab: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 3.16 Biosimilar Bevacizumab: Compounds in the Pipeline, 2013

Table 3.17 Biosimilar Bevacizumab: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 4.1 Biosimilar MAb Versions on the Market: Revenues ($m) and Market Shares (%), 2012

Table 4.2 Biosimilar Versions on the Market and in the Pipeline: Revenue Forecasts ($m), 2012-2023

Table 4.3 Celltrion's Remsima: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 4.4 Epirus Biopharmaceuticals' BOW-015: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 4.5 Dr. Reddy's Reditux: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 4.6 Boehringer Ingelheim's BI695500: Revenue Forecast, 2012-2023

Table 4.7 Celltrion's CT-P10: Revenue ($m) and Market Share (%) Forecast, 2012-2023

Table 4.8 Boehringer Ingelheim's BI695501: Revenue ($m) and Mark
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
2. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
3. Novation Supports New Development in the U.S. Biosimilar Pharmaceuticals Market
4. ASBM Survey Reveals Key Safety Concern Associated with Biosimilar Naming; Urges Distinct Naming Requirement
5. Reliance Pharmaceuticals: Biosimilars Company Analysis
6. Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets
7. Ground Zero Pharmaceuticals, Inc. (GZP) Announces Enhanced Biosimilars and Personalized Medicine Initiatives for its Clients
8. Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
9. Musculoskeletal Network Launches Special Coverage of FDA Biosimilars Policy
10. Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities
11. Global Biosimilars: A return to optimism?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 Arbor Pharmaceuticals, LLC. - ... Global Markets Direct,s, ,Arbor Pharmaceuticals, LLC. - Product ... the Arbor Pharmaceuticals, LLC.,s pharmaceutical research and development ... the current therapeutic developmental pipeline of Arbor Pharmaceuticals, ... therapeutics assessment by drug target, mechanism of action ...
(Date:9/30/2014)... 2014 According to ... by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments ... Application (Immunology, Oncology) & by End User ... MarketsandMarkets, provides a detailed overview of the ... trends, and strategies impacting the global glycomics ...
(Date:9/30/2014)... Quebec , Sept. 30, 2014 Valeant ... TSX: VRX) today announced that the company,s ... Letter from the U.S. Food and Drug Administration (FDA) ... Company,s records with regards to Sculptra Aesthetic injectable, which ... Warning Letter pertains to the management of Valeant,s contract manufacturers ...
Breaking Medicine Technology:Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
(Date:9/30/2014)... conceived either less than one year or more than five ... increased risk for autism, a new study suggests. However, ... that the research can,t prove that birth spacing has any ... that parents understand that the odds for autism are still ... apart," said outside expert Dr. Andrew Adesman. He is chief ...
(Date:9/30/2014)... carbon emissions will reduce other harmful air pollution ... a new study released today. The research shows ... the final Clean Power Plan, the power plant ... hospitalizations, and hundreds of heart attacks in the ... Health Co-benefits of Carbon Standards for Existing Power ...
(Date:9/30/2014)... Health Day Reporter ... patients who are overweight or obese when diagnosed appear ... second weight-related cancer, new research suggests. , , The ... recurrence, only the potential for developing other cancers associated ... survivors who reported being overweight or obese prior to ...
(Date:9/30/2014)... lung cancer, breast cancer is the leading cause of ... Society. That,s why so many medical professionals encourage women ... at best: only a minority of suspicious mammograms actually ... lots of needless worry for women and their familiesnot ... tests, including ultrasounds and biopsies. , Recently, a ...
(Date:9/30/2014)... 2014 Keystone Symposia will convene the first conference ... 2014-15 Global Health Series on "The Modes of ... immediately following the conclusion of the Grand Challenges ... part of the Keystone Symposia Global Health Series, supported ... also funded travel awards for 36 investigators from developing ...
Breaking Medicine News(10 mins):Health News:Spacing Between Sibling Births Tied to Autism Risk in Study 2Health News:Power plant standards could save thousands of US lives every year 2Health News:Power plant standards could save thousands of US lives every year 3Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:'Virtual breast' could improve cancer detection 2Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2
... new modus operandi at Britain’s farm ministry, with a view ... in the bud, as a preparation before the autumn season. ... gulls and waders, seen as potential H5N1 disseminators of infection ... surveillance and testing in the areas frequented by migratory birds. ...
... adults are estimated to use complementary and alternative therapies ... results of a// national survey published in the September ... issue on sleep. ,Approximately 10 to 34 ... as insomnia, according to background information in the article. ...
... Thiruvananthapuram said that there was no need to panic after ... were reported in the city.// ,Health authorities said that ... to pelt the state. The chikungunya scare so far was ... be confined to some pockets as mosquitoes are increasing due ...
... mosquito-caused illness is causing panic in the city.// ,As per ... city but four patients with its symptoms are being treated. Their ... have already started a survey in the city to identify chikungunya ... medical officer D.C. Jain. ,However, there is panic in ...
... fires have forced over 1,300 people to leave their ... to battle// the hundreds of forest fires on Friday. ... worst that they have ever encountered at this time ... with smoke vulnerability like children, the elderly, the infirm ...
... study directed by Mount Sinai School of Medicine ... regimens// might halt or even reverse symptoms of ... Attenuates Alzheimer’s Disease Type Brain Amyloidosis in Squirrel ... will be published in the November 2006 issue ...
Cached Medicine News:Health News:About 5 Percent of Adults with Insomnia Use Alternative Therapies 2Health News:Chikungunya Outbreak Feared in Jaipur 2Health News:Burning fires in Northern Ontario Cause Hundreds to leave their Homes 2Health News:Calorie Restriction May Prevent, Reduce Alzheimer’s Neuropatholog 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: